caa a22 4500 477037739 CHVBK 20180405111309.0 cr unu---uuuuu 170330e19960901xx s 000 0 eng 10.1007/BF00046342 doi (NATIONALLICENCE)springer-10.1007/BF00046342 Vile Richard Imperial Cancer Research Fund Laboratory of Cancer Gene Therapy, St. Thomas' Hospital, London, UK aut Gene therapy for cancer-in the dock, blown off course or full speed ahead? [Elektronische Daten] [Richard Vile] Gene therapy no longer seems to generate the unlimited optimism that it once inspired. So much so that the field has recently attracted the close scrutinies of the Director of the NIH himself. In this introductory chapter, the background is presented to the rise, and apparent decline, of the gene therapy of cancer and serves as a prelude to this issue of Cancer Metastasis Reviews which is designed to ask whether the field is worthy of its highly-priced and highly-hyped market profile. Kluwer Academic Publishers, 1996 gene therapy nationallicence cancer nationallicence Cancer and Metastasis Reviews Kluwer Academic Publishers 15/3(1996-09-01), 283-286 0167-7659 15:3<283 1996 15 10555 https://doi.org/10.1007/BF00046342 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF00046342 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Vile Richard Imperial Cancer Research Fund Laboratory of Cancer Gene Therapy, St. Thomas' Hospital, London, UK aut NATIONALLICENCE 773 0- Cancer and Metastasis Reviews Kluwer Academic Publishers 15/3(1996-09-01), 283-286 0167-7659 15:3<283 1996 15 10555 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer